0001209191-23-006935.txt : 20230203 0001209191-23-006935.hdr.sgml : 20230203 20230203164548 ACCESSION NUMBER: 0001209191-23-006935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230202 FILED AS OF DATE: 20230203 DATE AS OF CHANGE: 20230203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Noci Darlene CENTRAL INDEX KEY: 0001862148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 23586697 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-02 0 0001861560 Nuvalent, Inc. NUVL 0001862148 Noci Darlene C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Development Officer Class A Common Stock 2023-02-02 4 M 0 3000 1.08 A 3000 D Class A Common Stock 2023-02-02 4 S 0 1988 29.37 D 1012 D Class A Common Stock 2023-02-02 4 S 0 1012 29.92 D 0 D Stock Option (Right to Buy) 1.08 2023-02-02 4 M 0 3000 0.00 D 2031-02-15 Class A Common Stock 3000 120389 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2022. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.83 to $29.82, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.83 to $30.04, inclusive. The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. /s/ Deborah A. Miller, attorney-in-fact 2023-02-03